help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on March 5, 2003, doi:10.1164/rccm.200212-1508OC

Am. J. Respir. Crit. Care Med., Volume 167, Number 11, June 2003, 1504-1508

A more recent version of this article appeared on June 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200212-1508OCv1
167/11/1504    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korsgren, M.
Right arrow Articles by Greiff, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korsgren, M.
Right arrow Articles by Greiff, L.

Submitted on January 3, 2003
Accepted on March 5, 2003

Neural expression and increased lavage fluid levels of secretoneurin in seasonal allergic rhinitis

Magnus Korsgren1*, Jonas S Erjefalt2, Josef Hinterholzl3, Reiner Fischer-Colbrie3, Cecilia Ahlstrom Emanuelsson4, Morgan Andersson4, Carl G.A. Persson1, Alan Mackay-Sim5, Frank Sundler2, and Lennart Greiff6

1 Clinical Pharmacology, Lund University Hospital, Lund, Sweden, 2 Physiological Sciences, Lund University, Lund, Sweden, 3 Pharmacology, Innsbruck University, Innsbruck, Austria, 4 Otorhinolaryngology, Lund University Hospital, Lund, Sweden, 5 School of Biomolecular and Biomedical Science, Griffith University, Brisbane, Australia, 6 Otorhinolaryngology, Lund University Hospital, Lund, Sweden; School of Biomolecular and Biomedical Science, Griffith University, Brisbane, Australia

* To whom correspondence should be addressed. E-mail: magnus.korsgren{at}klinfarm.lu.se.

Secretoneurin is a neuropeptide potentially involved in migration of eosinophils, monocytes, and dendritic cells. Whether secretoneurin is present in the human airway mucosa and whether it is released at ongoing allergic airway inflammation is currently unknown. In patients with allergic rhinitis, we have explored the occurrence of secretoneurin in nasal mucosal biopsies and lavage fluids before and during natural allergen exposure. Immunohistochemical analysis revealed an abundance of nerves displaying secretoneurin immunoreactivity, which were distributed predominantly around blood vessels and submucosal glands. A majority of nerve fibers containing vesicular acetylcholine transporter, tyrosine hydroxylase, calcitonin gene-related peptide, and vasoactive intestinal peptide were also secretoneurin-immunoreactive, indicating a localization of secretoneurin in cholinergic, adrenergic, and sensory nerves. Lavage fluid levels of secretoneurin were increased at allergen exposure (p<0.01-0.05). Levels of secretoneurin did not correlate with eosinophil cationic protein (rho=0.1, p=0.7). We conclude that secretoneurin has a widespread occurrence in nasal mucosal nerves of patients with seasonal allergic rhinitis and that increased nasal lavage fluid levels of secretoneurin may characterize ongoing allergen exposure. These data favor a role of secretoneurin in the local traffic of immune cells in human airway mucosa.


Key words: Allergic airway inflammation, neuropeptides, eosinophils




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 265 - 276.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society
  Red In Translatin